This change was accompanied by a marked decrease in bromodeoxyuridine (BrdU) labeling of hepatocytes within AHF together with a significant increase in apoptosis of such cells measured by nick end-labeling. Similar but lesser effects were noted in surrounding, nonfocal hepatocytes. On refeeding, both the numbers and volume percentage of AHF returned within 2 weeks to values seen in nonfasted controls. Administration of PB during the fasting period did not alter these results, although AHF reappeared more rapidly in such animals on refeeding. Nuclear DNA fragmentation was evident in samples of whole liver from fasted animals. During this same period the expression of c-myc mRNA increased 3-to 9-fold, while levels of albumin and insulin-like growth factor I mRNAs decreased significantly. This study demonstrates a model system in which the reversibility of the effects of promoting agents may be rapidly determined and the effects of chemopreventive inhibitors of promotion may be rapidly evaluated.
Studies of the multistage nature of hepatocarcinogenesis in the rat have led to the development of models that have significant potential application to carcinogenesis in other tissues and other species, including humans (Farber and Sarma, 1987; Oesterle et al., 1989; Pitot et al., 1996) . These models, which almost completely parallel multistage epidermal carcinogenesis in the mouse (Hennings et al., 1993; Yuspa, 1994) , consist of 3 sequential, definable stages termed initiation, promotion, and progression. The stages of initiation and progression involve genetic alterations. In the stage of initiation such alterations appear to be relatively simple, involving specific bases or small sequences within single genes, whereas the genetic abnormalities seen in the stage of progression are much more complex, involving gene amplification, translocation, and deletion with associated chromosomal abnormalities (Pitot, 1997) . On the other hand, the intermediate stage of promotion does not directly involve alterations in the structure of the genome; rather, it is characterized by reversible changes in gene expression induced by external agents, termed promoting agents, on a background of mutations resulting from the initiation process. The reversibility of altered gene expression seen in this stage extends to the operational reversibility of the stage itself, based on cellular changes. Thus, lesions developing during the stage of promotion may disappear on removal of the promoting agent from the environment, or the effect of the promoting agent may be abrogated, either by an alteration in the format of its administration (Boutwell, 1964) or by the simultaneous administration of substances interfering with its effect on gene expression (Bertram and Frank, 1993) .
A major problem in our understanding of the reversal of the stage of promotion is whether it also modifies the stage of initiation. Several studies in the mouse epidermal carcinogenesis model have argued that modification or prevention of the development of the stage of promotion does not affect initiation (Van Duuren et al., 1975; Loehrke et al., 1983) . Similarly, in multistage hepatocarcinogenesis in the rat, removal from the diet of the promoting agent, phenobarbital, results in a rapid loss of approximately one-half or more of the preneoplastic lesions (altered hepatic foci), but with rapid reappearance upon readministration of the promoting agent, even after a period of 30 days (Hendrich et al., 1986) . By contrast, food restriction appears to eliminate preneoplastic lesions, which may not reappear when animals are re-administered the promoting agent, nafenopin (Grasl-Kraupp et al., 1994) . We have recently reported that two sequential 5-day periods of fasting and sub-sequent refeeding caused a dramatic loss of preneoplastic lesions followed by an accelerated growth of the altered hepatic foci, and resulting in a complete repopulation, both numerically and in volume, of the lesions that had been lost on fasting (Hikita et al., 1998) . It is the purpose of this discussion to compare several models and to consider the mechanisms for the reversibility of promotion in multistage hepatocarcinogenesis in the rat.
MATERIALS AND METHODS
The methodology and materials that have been employed in the experiments to be described have been published previously (Hikita et al., 1998) and will be presented only briefly in this section. The protocol for the fasting regimens superimposed on an initiation-promotion sequence is seen in Figure 1 . Sixweek-old female Sprague-Dawley rats (Harlan Sprague-Dawley, Madison, WI) were divided into 3 groups. The initiation-promotion protocol previously described in this laboratory (Pitot et al., 1978) was employed, and animals in groups B and C were subjected to 2 sequential 5-day fasts from days 28 to 33 and 35 to 40, respectively, on the protocol. At all other times the animals were given laboratory chow diet ad libitum. Phenobarbital (0.05%) was in the drinking water available at all times except during the 28-to 40-day interval in group C. Groups of 6 animals were sacrificed at the times indicated by S. At appropriate times, bromodeoxyuridine (100 mg/kg body weight) was administered intraperitoneally 2 h before sacrifice. At the time of sacrifice, liver and body weights were determined, livers were cut into 2-to 3-mm slices, and were fixed in cold acetone or buffered formalin for 24 h. The remaining liver tissue was frozen in liquid nitrogen for DNA and RNA isolation. Histologic and immunochemical analyses, as well as the stereologic determination of AHF number and volume percentage, were carried out as previously described (Campbell et al., 1986; Hikita et al., 1998) . The nick end-labeling technique, DNA fragmentation assay, isolation of RNA, and Northern blot analyses were carried out as previously described (Hikita et al., 1998) .
RESULTS
One of the earliest investigations on the reversal of the stage of promotion, although not specifically designated as such, was the study by Teebor and Becker (1971) , who demonstrated the regression of some but not all hyperplastic hepatic nodules induced by 2-acetylaminofluorene (2-AAF). This study demonstrated that administration of the carcinogen for 3 months or less yielded a large number of nodules, most of which regressed after withdrawal of the carcinogen. A subsequent study was that of Farber and his colleagues, who described a format of hepatocarcinogenesis resulting in the rapid appearance of pre-neoplastic altered hepatic foci (AHF). This was followed by rapid loss of the vast majority of AHF following removal of the "promoting agent," in this case 2-acetylaminofluorene, a complete carcinogen (Solt and Farber, 1976) . The instability of these preneoplastic lesions has been demonstrated by numerous investigations in several models (Kolaja et al., 1996; Tatematsu et al., 1983; van der Heijden and Dormans, 1981) . In a somewhat more extended model developed in our laboratory, Hendrich et al. (1986) found that animals initiated with a nonnecrogenic dose of DEN and administered the promoting agent, phenobarbital, for 4 months lost more than 50% of the total number of AHF upon removal of the phenobarbital from the diet for 30 days. Re-administration of the promoting agent at the end of this time resulted in the reappearance of the same number of AHF as had occurred at the time of withdrawal of the promoting agent. These data are seen in Figure 2 , reproduced from this earlier study (Hendrich et al., 1986) . Three different enzyme markers were used to score the AHF, and the effects were present whether any one or all or a combination of markers were utilized for the analysis, as noted in the figure.
More recently, using a model involving the prolonged ad-
FIG. 2.
Effects of withdrawal and readministration of phenobarbital on the number of AHF in rats subjected to the initiation-promotion protocol of Pitot et al. (1978) for a period of 4 months, at which time PB was removed from the diet for a period of 30 days and, for some groups, re-administered for another 30 days. GGT ϭ ␥-glutamyltranspeptidase; ATP ϭ adenosinetriphosphatase; G6P ϭ glucose-6-phosphatase; ANY ϭ all foci analyzed. See original reference of Hendrich et al. (1986) for further experimental details. Reproduced with permission of authors and publisher.
FIG. 1.
Initiation protocol with two 5-day periods of fasting. Female Sprague-Dawley rats were divided into 3 groups and fed laboratory chow diet (containing approximately 24% protein) throughout the experiment, except during the fasting periods when no food was given. Phenobarbital was administered in the drinking water (0.05%), at all times, except during days 28 -40 for group C. See text for further details.
ministration of a promoting agent, nafenopin, Grasl-Kraupp and her associates (1994) demonstrated that a period of food restriction for 95 days, in a study extending almost 900 days in total, dramatically decreased the number of AHF and particularly the benign and malignant hepatic lesions occurring at the end of the experiment. The basic study is reproduced in Figure  3 , demonstrating the rapid loss of AHF in animals subjected to a food-restricted diet (FR) during this period. At the end of that time, the promoting agent was administered for the remaining 500 days of the experiment. Although there was a dramatic recovery of the AHF when ad libitum feeding was resumed at day 380, and a continued increase in AHF number occurred throughout the remainder of the experiment, the number of benign and malignant neoplasms in the liver was dramatically reduced at the end of the study. On the basis of their previous studies reported in this paper, the authors argued that caloric restriction enhanced apoptosis of hepatocytes, eliminating initiated cells and resulting in the final effect on gross neoplasms, although the numbers of AHF were not significantly different in the 2 groups at the end of the experiment (Fig. 3) . This study prompted us to determine whether short-term acute fasting could achieve the same effect but over a much shorter period of time. Grasl-Kraupp et al. (1994) had demonstrated in their study that an 8-day fast resulted in dramatic decreases in liver DNA content and increased apoptotic activity of hepatocytes, especially during the last 2 days of the fast. Our study employed female rats of the same age as those used by GraslKraupp and her associates, and they were subjected to the format seen in Figure 1 . Two 5-day periods of fasting were employed in an attempt to adapt the animal rapidly to a fasting situation. At the end of these two periods of fasting, body weight decreased by more than 30%, while the liver weight decreased by some 60%. The presence or absence of the promoting agent phenobarbital during the fasting period had no effect on these changes. At the same time, the number of AHF in the liver decreased to near zero, as noted in Figure 4 . Again, the presence of the promoting agent did not seem to affect the loss of AHF, but on refeeding for 1 week the number of AHF in livers of animals receiving PB during the fasting period had returned almost to normal. By 2 weeks of refeeding, the numbers of AHF in livers of both fasted groups were approaching control levels.
During the period of fasting, there was a dramatic decrease in the BrdU-labeling indices in both the AHF and the surrounding hepatocytes. After refeeding for 1 week, there was a dramatic increase in BrdU labeling, exceeding that seen in control, nonfasted animals (Fig. 5) . It should be noted from Figure 5 that the labeling index of the AHF is 10-fold greater than that seen in the surrounding, nonfocal hepatocytes. Changes in the apoptotic index measured by nick-end-labeling (NEL) were dramatically higher in surrounding, nonfocal hepatocytes after the fasting period. However, cells of AHF already exhibited a 4-fold higher level of apoptosis in the nonfasted state, which was doubled following fasting (Fig. 6 ). Upon refeeding, the values returned to those levels seen prior to the fast (Hikita et al., 1998) . While the degree of DNA fragmentation was sufficiently extensive in the liver as a whole to be able to demonstrate laddering by electrophoresis (Hikita et al., 1997) , the vast majority of the surrounding, nonfocal hepatocytes were not undergoing apoptosis at the time the samples were taken. By contrast, because only about 0.2% of the liver volume was occupied by AHF, the extensive loss of number and volume percentage of AHF could be accounted for almost entirely by apoptosis of these cells in the absence of cell replication.
In view of the extensive apoptosis noted in the liver parenchyma after the 2 fasting periods, it was of interest to determine whether alterations in the expression of genes involved in hepatocyte growth and apoptosis could be identified. Figure 7 FIG. 4. Number of altered hepatic foci (AHF) in livers of animals subjected to the format seen in Figure 1 and sacrificed on the days indicated in this figure. Treatment groups are designated as shown in Figure 1 . Stat-View software for the Macintosh microcomputer was used for statistical analyses, and significant differences were determined by the Mann-Whitney test. In the figure, a indicates significant differences from group A at all times.
FIG. 3.
Effect of food restriction for 95 days on the number of spontaneously occurring AHF in rats subsequently administered nafenopin (100 mg/ kg/day) (NAF). FR ϭ food restriction; PPF ϭ AHF. Adapted from GraslKraupp et al. (1994) with permission of authors and publisher.
shows the quantification of the expression of several such genes, measured as mRNA on Northern blots. The expression of genes in the fasted groups is presented as a percentage of the nonfasted controls taken as 100. ␤-Actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were studied as loading controls, although there was in fact some change in the expression of these genes during the study (Hikita et al., 1998) . The most striking effects are seen with albumin (alb) and the insulin-like growth factor I (IGF-I), where there was a dramatic decrease in the expression of these 2 genes as measured by their mRNA levels. By contrast, the expression of the protooncogene, c-myc, was enhanced some 7-to 9-fold over control levels and 3-fold or more over the loading control levels. Expression of p53 was significantly increased over the fedcontrol level of this mRNA, but was not significantly different from the levels of the loading controls. IGF-II and Bcl-2 mRNAs could not be detected during the fasting and refeeding periods or in control livers.
DISCUSSION
The stage of promotion can be readily defined in experimental models of carcinogenesis in rodents, especially multistage hepatocarcinogenesis in the rat and multistage epidermal carcinogenesis in the mouse. Since many endogenous agents such as sex hormones and trophic polypeptide hormones are promoting agents (Pitot, 1991) , the effect of these endogenous promoting agents contributes to carcinogenesis, both from induced and spontaneous or background sources. Because of this effect, in experimental situations administration of a single or a few necrogenic doses of complete carcinogens that induce neoplasia has led some to the conclusion that either the stage of tumor promotion does not exist or that promoting agents have relatively small effects under such circumstances (Bannasch and Zerban, 1986) . Furthermore, the chronic administration of excessive doses of promoting agents, which leads to cell necrosis and apoptosis with subsequent, compensatory cell division, has not always been considered reflective of a non- Fig. 1 ). The surrounding, nonfocal hepatic tissue is indicated as GST-, while the altered hepatic foci are designated as GSTϩ. Statistical analyses are as in Figure 4 .
FIG. 7.
Quantification of mRNAs in livers of animals subjected to the format seen in Figure 1 . For each gene product, the expression at day 40 in groups B and C (Fig. 1) is given as a percentage of group A on day 40. All differences were significant at p Ͻ 0.05, except for IGF-I in group B.
genotoxic mechanism characteristic of promoting agents (Cunningham, 1996) .
It has been possible in multistage rat hepatocarcinogenesis to define, in relatively stringent terms, the stage of promotion after initiation by a nonnecrogenic dose of initiating agent. The subsequent progeny of initiated cells, which comprise the stage of promotion, are euploid, exhibiting no evidence of karyotypic instability (Sargent et al., 1989) . By committing to such a rigorous operational definition, it becomes possible to study the characteristics of the stage and the effect of agents and processes on its development. As noted earlier, the major characteristics of promotion are its operational reversibility and its dependence on induced, altered gene expression. Another critical factor is that the initiated cell population and its progeny in the stage of promotion exhibit effects that are selective in their action on the promoted cell population. This can be noted in the effect of acute fasting on the preneoplastic population of altered hepatic foci. The dramatic loss of replicative activity of this relatively small cellular population, by at least one order of magnitude greater than the normal hepatocyte population, exemplifies this relatively large effect of fasting on the preneoplastic cell population. The apoptotic index is roughly the same as that of the "normal" liver parenchymal cells, but in absolute numbers nearly 99% of cells within AHF were eliminated (Figs. 4 and 6 ). Apoptosis plays an important role both in cell deletion during caloric restriction and in the loss of liver weight and DNA during starvation (Grasl-Kraupp et al., 1994) . Previous studies (Stinchcombe et al., 1995; Schulte-Hermann et al., 1993) have indicated that promoting agents can inhibit apoptosis, which occurs normally in hepatocytes as well as in AHF. From these studies, at least one promoting agent, phenobarbital, exhibited little inhibition of apoptosis during the fasting period (Hikita et al., 1998) , although on refeeding, AHF in the livers of animals administered PB during the fasting periods recovered to control levels at a faster rate than those without PB.
During the fasting period, total hepatic RNA decreased significantly (Hikita et al., 1998) , but individual mRNAs were both increased and decreased, as seen in Figure 7 . The internal loading controls that were utilized, ␤-actin and GAPDH mRNAs, were themselves elevated 2-to 3-fold, whereas albumin mRNA and the level of insulin growth factor-I mRNA decreased dramatically during the fasting period. Previous studies have demonstrated a decrease in the levels of some mRNA species in rat liver after various periods of fasting (Colosia et al., 1988; Hayden et al., 1994) . However, the levels of other mRNA species increased in the liver (Argaud et al., 1996) and small intestine (Watford and Tatro, 1989) when rats were fasted for up to 7 days. Significant decreases in functional albumin mRNA upon short-term fasting have also been reported by others (Howard et al., 1986) . In contrast to the effects seen with IGF-I, others have reported increases in mRNA levels of IGF-II (Straus, 1994) , a finding we were unable to repeat in our studies. IGF-II expression is normally not detectable in adult rat liver (Ueno et al., 1988) , but fetal growth retardation caused by maternal fasting does lead to a lowered expression of this growth factor (Straus et al., 1991) . Thus, the acute fasting regimen utilized in these and other studies demonstrates a reduction in the transcription of several secretory proteins and growth factors that are secreted by or have an effect on hepatocytes (Boisjoyeux et al., 1986; Straus et al., 1991) . The increases in ␤-actin and GAPDH during the fasting periods might be associated with the apoptotic cell loss induced by the fasting regimen in these studies. Previous investigations have demonstrated that the expression of these genes increases during liver regeneration after partial hepatectomy or after the administration of CCl 4 (Itoh et al., 1992; Sobczak et al., 1989) . The most dramatic effect noted in our studies was an increase in the relative levels of c-myc mRNA at the end of the fasting period. Levels of c-myc mRNA increased in rat liver with age (Matocha et al., 1987) , as well as on a protein-free diet (Horikawa et al., 1986) . Several studies in cell culture have demonstrated that proliferating cells in nutrient-rich medium express high levels of c-myc. When such cells are subjected to growth arrest while c-myc expression remains deregulated, many such cells undergo apoptosis (Askew et al., 1993; Evan et al., 1992) . IGF-I suppresses such c-myc-induced apoptosis seen in culture (Evan et al., 1994) . We would propose that in the liver of the acutely fasted animal in vivo, the deregulation of c-myc, either by increased rate of transcription or by mRNA stabilization in the absence of growth factors such as IGF-I, results in a dramatic enhancement of hepatocyte apoptosis by mechanisms that may be analogous to the c-myc-induced apoptosis in cell culture described above. Furthermore, enhanced expression of c-myc also occurs in some AHF (Deguchi and Pitot, 1995) , and such deregulation of this gene may, in the fasted state, lead to the greater degree of apoptosis noted in hepatocytes within AHF.
The model system of fasting and refeeding described in this paper offers the potential for reaching an understanding of the mechanisms of apoptosis that occur in hepatocytes under these conditions, as well as for its use as a model in testing the effect of inhibitors of the stage of promotion in a rapid, short-term, efficient system. Apoptosis in hepatocytes also appears to result from other mechanisms (Pitot, 1998) that may also function during the fasting-refeeding regimen described in this study. In preliminary investigations, levels of the expression of bcl-x and Bax, genes whose products are known to be involved in the apoptosis mechanisms in hepatocytes (Kren et al., 1996) , did not change significantly during the fasting and refeeding regimen. Thus, future experimentation will be directed toward both an examination of the expression of other genes potentially involved in the apoptotic mechanisms of hepatocytes and of the effectiveness of known chemopreventive agents in inhibiting the regrowth of preneoplastic AHF. Such studies should allow a better understanding both of the mechanisms of hepatocyte apoptosis and of the development and regulation of tumor promotion in multistage hepatocarcinogenesis.
